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A now 36-year-old woman developed a supra-
hepatic inferior vena cava stenosis, 9 years after
liver transplantation for extensive liver echinococ-
cosis. The lesion was treated by percutaneous an-
gioplasty and stenting. Five years later, recurrence
of echinococosis with intrastent stenosis together
with clinical symptoms, prompted surgical treat-
ment. Hepato-atrial anastomosis was performed
under cardiopulmonary bypass with good result.
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The management of hepatic venous outflow
obstruction is a complex problem due to the di-
verse pathologies involved. Medical therapy re-
mains limited, and the obstruction often recurs
after percutaneous endovascular procedures. Lo-
calization and anatomy of the confluence between
the hepatic veins and the inferior vena cava render
surgical approach difficult.
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Introduction
Clinical problem
A now 36-year-old woman underwent liver
transplantation in 1990 for extensive unresectable
liver alveolar echinococcosis. The evolution was
fine and marked by a successful pregnancy. How-
ever, in 1999 she developed a symptomatic supra-
hepatic inferior vena cava stenosis consecutive to
local echinococcosis recurrence. The stenosis was
treated by percutaneous angioplasty and stenting
with good clinical result. In 2004, the reappearance
of symptoms of exercise dyspnoea, legs swelling
and two episodes of syncope urged a complete
work-up. An intrastent restenosis was found caus-
ing a 10 mm Hg pressure gradient between the in-
ferior vena cava and the right atrium. The cardiac
output was measured at 3.26 l/min for a cardiac
index of 1.9 l/min/m2 proving the restrictive
haemodynamic effect of the lesion and explaining
the symptoms. After discussion with the patient
and her treating physicians, a surgical approach
was chosen which combined resection of the 
parasitic mass and hepato-atrial anastomosis. 
The operation was carried out through a median
sternotomy with beating heart under cardiopul-
monary bypass assistance with standard superior
vena cava venous canulation, the open inferior
vena cava being canulated from the groin with a
Smart canula [1]. The entire suprahepatic inferior
vena cava was resected together with the stent and
as much as possible of the parasitic mass cutting
Figure 1
Suprahepatic inferior
vena cava intrastent
restenosis.
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through the diaphragm into liver parenchyma, set-
ting free the orifices of major hepatic veins as re-
ported by Senning [2]. The vascular continuity was
then re-established by creating a tunnel between
the diaphragmatic orifice and the right atrium
using right atrial tissue for the posterior part and
equine pericardium for the anterior and lateral
parts. Equine pericardium had to be used since
most of the inferior vena cava was resected with the
lesion. Histopathology confirmed the diagnosis of
recurrent echinococcosis with an important in-
flammatory and granulomatous reaction. The op-
eration went well; the patient left the hospital on
post-operative day 12 under lifelong albendazol
treatment without any residual gradient measured
by Doppler ultrasound. Three months after the
operation, the patient was doing well and symp-
tom free.
Figure 2
Resection specimen
showing stent
invasion.
Discussion
Figure 3
Operative view 
showing completed
hepato-atrial
anastomosis.
Inoperable liver echinococcosis remains a rare
indication for liver transplantation, with as little as
42 cases reported in Europe between 1985 and
2002. Recurrence of the disease in this subgroup 
is common and certainly favoured by the use of
immunosuppressants [3].
Inferior vena cava obstruction following liver
transplantation is an uncommon complication
occurring in less than 2.5% of the cases, usually
resulting from technical problems such as com-
pression/torsion of the inferior vena cava [4].
Percutaneous endovascular treatment of
Budd-Chiari syndrome has been described [5, 6].
However, recurrences with stent thrombosis are
frequent, often with severe consequences [5], ne-
cessitating surgical interventions.
Different types of surgical therapies have been
proposed to relieve portal hypertension such as
mesoatrial or mesocaval shunts [7]. However, the
only intervention able to correct the underlying
problem, ie obstruction of the major hepatic veins,
is the operation first described by Åke Senning in
1983 under the name “Dorsocranial liver resection
and direct hepato-atrial anastomosis” [1]. Its first
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indication was the treatment of Budd-Chiari syn-
drome [8, 9] but it can also be used to address other
suprahepatic vena cava pathologies, including
trauma as has been reported in one case [10].
As liver transplantation has become the
treatment of choice for advanced Budd-Chiari
syndrome, hepato-atrial anastomosis fell into
oblivion despite good reported long term results
[11] without the complications of lifelong im-
munosuppressive therapy. However, irreversible
liver parenchyma damage and obstruction of small
sublobular and centrilobular veins, remain indica-
tions for liver transplantation. 
Although the surgical “Senning” technique is
not very well known, it deserves the attention of
practicing surgeons. It probably is the best ap-
proach to address hepatic venous outflow obstruc-
tions and suprahepatic vena cava pathologies of
diverse origins; it restores direct anatomic conti-
nuity, it can relieve obstruction of the major he-
patic veins and it can often be completed without
the use of any foreign material.
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